Doctors Note Logo

Published on: 7/21/2026

Doctor's Note: Are GLP-1s Messing with Your Hormones? What Perimenopausal Black Women Experience

GLP-1 medications such as Ozempic, Wegovy, and Zepbound support weight loss and blood sugar control, but they can indirectly disrupt hormone balance in perimenopausal Black women. Through rapid fat loss, insulin fluctuations, cortisol shifts, and reduced appetite, these drugs may intensify perimenopause symptoms like hot flashes, mood swings, and irregular menstrual cycles.

Key management strategies include tracking mood, sleep quality, and cycle dates, while prioritizing protein-rich nutrition, strength training, and stress reduction. Because perimenopause and GLP-1 side effects share overlapping symptoms, identifying the root cause is essential for effective care.

Not sure if your symptoms are from perimenopause, your medication, or something else entirely? Guessing wastes time—and the wrong assumption can delay real relief. Take a free, instant, online symptom check to get personalized insights based on your unique health profile. In just a few minutes, you'll better understand what's driving your symptoms and know exactly which next steps to take, whether that's adjusting your routine or talking to your doctor.

Reviewed for medical accuracy: 07/21/2026

answer background

Explanation

Doctor's Note: Are GLP-1s Messing with Your Hormones?

What Perimenopausal Black Women Experience

Perimenopause—the transitional phase before menopause—brings unpredictable hormone swings, mood shifts and changes in metabolism. Lately, many women are prescribed GLP-1 receptor agonists (like Ozempic, Wegovy and the newly approved Zepbound) to help control weight and blood sugar. If you're a perimenopausal Black woman taking Zepbound or another GLP-1, you may wonder: "Are these meds messing with my hormones—and my mood?" Here's what current research and clinical experience tell us.


Understanding GLP-1 Medications

Glucagon-like peptide-1 (GLP-1) agonists mimic a hormone that stimulates insulin release, slows stomach emptying and reduces appetite. Common brand names include:

  • Ozempic (semaglutide)
  • Wegovy (higher-dose semaglutide)
  • Zepbound (a newer weekly semaglutide formulation)

Doctors originally prescribed GLP-1s for type 2 diabetes. Today, many perimenopausal women use them off-label to manage stubborn weight gain—an issue especially common during hormonal transition.


Hormonal Changes in Perimenopause

During perimenopause, your ovaries gradually produce less estrogen and progesterone. This fluctuation can lead to:

  • Irregular cycles—periods come early, late or skip entirely
  • Hot flashes and night sweats
  • Sleep disturbances
  • Mood swings and irritability
  • Weight redistribution—more belly fat, less muscle

These shifts affect not only reproductive hormones but also metabolic and stress hormones (cortisol), making perimenopause a uniquely challenging time.


How GLP-1s Might Influence Your Hormones

Current evidence suggests GLP-1 medications do not directly reduce estrogen or progesterone. However, they can indirectly affect your hormonal balance in several ways:

  1. Weight Loss and Fat Distribution

    • Losing fat—especially visceral belly fat—can alter estrogen production. Fat tissue makes estrogen, so significant weight loss may lower overall levels, potentially worsening hot flashes or mood swings.
  2. Insulin and Cortisol Regulation

    • Better blood sugar control may stabilize cortisol (stress hormone) peaks, sometimes improving anxiety or sleep—but in other cases, changing cortisol rhythms can temporarily disrupt mood.
  3. Appetite and Nutrition

    • Reduced appetite or mild nausea can lead to lower caloric or nutrient intake. If you miss essential vitamins or minerals (like B vitamins, magnesium or iron), you might feel more fatigued, irritable or down.
  4. Menstrual Cycle Changes

    • Some women report lighter or fewer periods on GLP-1s, likely due to weight loss. Others see more irregular cycles. Any sudden cycle change can amplify perimenopause mood swings.

What Black Women Specifically May Experience

Perimenopausal Black women often face higher rates of obesity, hypertension and type 2 diabetes—conditions for which GLP-1s are frequently prescribed. Unique factors include:

  • Genetic and metabolic differences
  • Higher likelihood of visceral fat accumulation
  • Cultural attitudes toward body image and weight loss
  • Barriers to healthcare access and provider bias

These factors can shape how you respond to Zepbound or other GLP-1s, and how you perceive mood swings or menstrual changes. Open communication with your provider is key.


Recognizing Overlapping Symptoms

Mood swings are a hallmark of perimenopause. But GLP-1 side effects—nausea, fatigue or low mood—can feel similar. Here's how to spot the difference:

  • Perimenopause mood swings

    • Often tied to your cycle (tracking dates helps)
    • May include sudden irritability, tearfulness or anxiety
    • Can worsen with poor sleep or hot flashes
  • GLP-1–related mood effects

    • Might appear soon after starting or upping dose
    • Often coincide with appetite changes or mild nausea
    • Usually stabilize after 4–6 weeks as your body adjusts

Keep a daily log of your mood, appetite, sleep quality and menstrual dates. Over time, patterns emerge—and your doctor can use that data to separate perimenopausal shifts from medication-related effects.


Tips to Tame Zepbound and Perimenopause Mood Swings

Managing overlapping hormone and medication effects takes a multi-layered approach. Consider:

• Nutrition Focus

  • Small, balanced meals with protein, healthy fats and fiber
  • Monitor nutrient intake—especially B vitamins, vitamin D, magnesium and iron
  • Stay hydrated; nausea often worsens if you skip fluids

• Gentle Movement

  • Aim for 20–30 minutes of walking, yoga or resistance training most days
  • Exercise helps regulate cortisol, insulin sensitivity and mood

• Sleep Hygiene

  • Keep a consistent sleep schedule
  • Limit screens 1 hour before bedtime
  • Use breathable sheets; night sweats can disrupt sleep

• Stress Management

  • Practice deep breathing or mindfulness for 5–10 minutes daily
  • Schedule short mental-health breaks during the day

• Social Support

  • Connect with friends or a menopause support group
  • Sharing experiences reduces isolation and normalizes mood swings

When to Talk to Your Doctor

Any new or worsening symptom deserves attention—especially if it's life-threatening or severely impacts daily life. Consider seeking medical advice if you experience:

  • Chest pain, shortness of breath or fainting
  • Severe abdominal pain or persistent nausea/vomiting
  • Sudden mood changes that include self-harm thoughts
  • Any sign of allergic reaction (rash, swelling, difficulty breathing)

If you're experiencing concerning symptoms but aren't sure whether they warrant an immediate doctor visit, you can use Ubie's Medically approved LLM Symptom Checker Chat Bot to help you understand your symptoms and decide on the best next steps before your appointment.


Tracking Progress and Adjusting Treatment

Regular follow-ups help your provider fine-tune therapy. You may discuss:

  • Adjusting Zepbound dose (smaller increments can ease side effects)
  • Adding hormone-supportive treatments (low-dose estrogen or progesterone creams)
  • Referrals to nutritionists, physical therapists or mental-health professionals

Always report new or troubling symptoms honestly—your safety and quality of life depend on it.


Key Takeaways

  • GLP-1 agonists like Zepbound can help with weight loss but may indirectly affect your hormones through fat loss, insulin shifts and appetite changes.
  • Perimenopause mood swings and GLP-1 side effects can overlap—tracking your cycle, mood, meals and sleep helps untangle them.
  • Black women often face unique metabolic and healthcare challenges; advocate for culturally sensitive, personalized care.
  • Lifestyle support—nutrition, movement, sleep, stress management and social connection—remains essential.
  • For any serious or life-threatening concerns, speak to a doctor immediately.

Always speak with a healthcare provider about any persistent, severe or worrisome symptoms. Your well-being is too important to leave to guesswork—professional guidance ensures you get the safest, most effective care.

(References)

  • * Khedr, E., Awad, O., El-Bahy, M. R., & Sabry, A. (2022). Glucagon-like peptide-1 (GLP-1) and sex hormones: A narrative review. *Journal of Clinical Endocrinology & Metabolism*, *107*(10), e4133-e4141.

  • * He, M., Zhao, S., Sun, J., & Ma, R. (2023). Impact of GLP-1 Receptor Agonists on Endocrine Systems: A Comprehensive Review. *Journal of Clinical Endocrinology & Metabolism*, *108*(10), 2530-2544.

  • * Harsløf, T., & Jensen, T. A. (2021). Metabolic and hormonal effects of GLP-1 receptor agonists beyond glucose lowering in type 2 diabetes. *Endocrinology, Diabetes & Metabolism*, *4*(4), e00270.

  • * Aiyer, A., Williams, N., Aravind, A. J., & Gadgil, K. K. (2024). Racial and ethnic disparities in response to weight loss medications in adults with overweight or obesity: a systematic review. *Obesity Reviews*, *25*(3), e13645.

  • * Sun, S., Wang, F., Guo, F., Li, Z., & Gao, R. (2024). The role of GLP-1 in female reproductive health: a systematic review. *Frontiers in Endocrinology*, *15*, 1342676.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.